Kozaily, Elie
Akdogan, Ecem Raziye
Dorsey, Natalie Stringer
Tedford, Ryan J.
Article History
Accepted: 29 January 2024
First Online: 1 April 2024
Change Date: 5 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11906-024-01305-4
Compliance with Ethical Standards
:
: Dr. Tedford reports no direct conflicts of interest related to this manuscript. He is co-chair of the PH due to left heart disease task force for the 7th World Symposium on Pulmonary Hypertension. He reports general disclosures to include consulting relationships with Medtronic, Abbott, Acorai, Aria CV Inc., Acceleron/Merck, Alleviant, Cytokinetics, Edwards LifeSciences, Gradient, Lexicon Pharmaceuticals, and United Therapeutics. Dr. Tedford serves on steering committees for Merck, Edwards, and Abbott as well as a research advisory board for Abiomed. He also does hemodynamic core lab work for Merck. All other authors report no disclosures related to this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.